Perspective Therapeutics, Inc.·4

Nov 17, 8:01 AM ET

Hunt Jonathan Robert 4

4 · Perspective Therapeutics, Inc. · Filed Nov 17, 2025

Insider Transaction Report

Form 4
Period: 2025-11-13
Hunt Jonathan Robert
Chief Accounting Officer
Transactions
  • Purchase

    Common Stock

    2025-11-13$2.03/sh+11,000$22,29559,800 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.0235 to $2.0300, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4